Form 4 for VOR Vor Biopharma Inc.
Accepted 2025-02-18 00:00:00 ET · period of report 2025-02-13 · accession 0001415889-25-004406 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-18 | 2025-02-13 | VOR | Attar Eyal C. | Chief MEDICAL Off | S - Sale | $1.42 | -2,227 | 126.6K | -2% | -$3,162 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-13 | S | D | 2,227 | $1.42 | 126,625 | D | — | — |